Genotoxicity associated with the use of tyrosine kinase inhibitors in patients with chronic myeloid leukemia.

about

Genotoxicity associated with the use of tyrosine kinase inhibitors in patients with chronic myeloid leukemia.

Item

http://www.wikidata.org/entity/Q48333828

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Genotoxicity associated with t ...... with chronic myeloid leukemia.

@en

Genotoxicity associated with t ...... with chronic myeloid leukemia.

@nl

type

Item

label

Genotoxicity associated with t ...... with chronic myeloid leukemia.

@en

Genotoxicity associated with t ...... with chronic myeloid leukemia.

@nl

prefLabel

Genotoxicity associated with t ...... with chronic myeloid leukemia.

@en

Genotoxicity associated with t ...... with chronic myeloid leukemia.

@nl

P1476

Genotoxicity associated with t ...... with chronic myeloid leukemia.

@en

P2093

Acy Telles de Souza Quixadá

http://www.w3.org/2001/XMLSchema#string

Bruno Coêlho Cavalcanti

http://www.w3.org/2001/XMLSchema#string

Fernando Barroso Duarte

http://www.w3.org/2001/XMLSchema#string

Jamilly Florêncio Pereira

http://www.w3.org/2001/XMLSchema#string

Marilena Facundo de Castro

http://www.w3.org/2001/XMLSchema#string

Maritza Cavalcante Barbosa

http://www.w3.org/2001/XMLSchema#string

Rommel Rodriguez Burbano

http://www.w3.org/2001/XMLSchema#string

Romélia Pinheiro Gonçalves Lemes

http://www.w3.org/2001/XMLSchema#string

Tarcísio Paulo de Almeida Filho

http://www.w3.org/2001/XMLSchema#string

P2860

The Philadelphia chromosome in leukemogenesis

A simple technique for quantitation of low levels of DNA damage in individual cells

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

Clonal cytogenetic abnormalities in Philadelphia chromosome negative cells in chronic myeloid leukemia patients treated with imatinib.

Serum concentrations of nitrite and malondialdehyde as markers of oxidative stress in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors

Genomic instability may originate from imatinib-refractory chronic myeloid leukemia stem cells.

Amphetamines promote mitochondrial dysfunction and DNA damage in pulmonary hypertension

Chronic myeloid leukemia: 2016 update on diagnosis, therapy, and monitoring.

Chromosomal abnormalities in Philadelphia chromosome-negative metaphases appearing during imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase.

Detection of trisomy 8 in donor-derived Ph- cells in a patient with Ph+ chronic myeloid leukemia successfully treated with Imatinib (STI571) in relapse after allogeneic transplantation.

P304

260-262

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/EM.22164

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Edivaldo De Oliveira

Caroline Aquino Moreira-Nunes

Romélia Pinheiro Gonçalves Lemes

Pedro Aurio Maia Filho

P577

2017-12-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29285791

http://www.w3.org/2001/XMLSchema#string

P921

chronic myeloid leukemia